Sialylation patterns in cerebral amyloid angiopathy

Area of Science:

• Neuroscience
• Biochemistry
• Immunology

Background:

• Glycosylation, a common brain modification, is altered in neurodegeneration, often showing increased sialic acid (SA).
• Previous research linked increased sialylation to microglia in Alzheimer's disease (AD), especially near amyloid plaques.
• The relationship between SA and Cerebral Amyloid Angiopathy (CAA), common in AD, remains poorly understood.

Purpose of the Study:

• To investigate sialylation patterns in AD cases with and without CAA.
• To compare SA modifications in parenchymal and leptomeningeal vessels across different patient groups.

Main Methods:

• Analysis of 30 post-mortem frontal cortex cases with diagnoses of AD and/or CAA.
• Quantitative digital pathology to assess regional SA differences in blood vessels.
• Comparison of intravascular amyloid-beta and SA levels between AD with CAA, AD-only, and control groups.

Main Results:

• No significant difference in amyloid-beta levels within vessels of AD with CAA cases.
• Visual increase in microglia sialylation observed around parenchymal blood vessels in CAA cases.
• Significantly higher intravascular SA levels in AD with CAA cases compared to AD-only and control groups.

Conclusions:

• This study reveals elevated sialylation in cerebral blood vessels in AD with CAA.
• The findings suggest altered glycosylation contributes to pathology in AD with CAA.
• Further research into glycosylation changes is warranted for understanding AD with CAA progression.